A Cost-Benefit Analysis of Prenatal Screening for Toxoplasmosis
The objective of this study was to examine critically the validity of a toxoplasma prenatal screening program, in the context of a cost-benefit analysis, as it relates to the Canadian experience. Recently, studies have suggested that early treatment of infected infants with a combination of pyrimeth...
Saved in:
| Main Authors: | Vic S Sahai, Heather Onyett |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1996-01-01
|
| Series: | Canadian Journal of Infectious Diseases |
| Online Access: | http://dx.doi.org/10.1155/1996/678145 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potential bias in the analysis of prenatal treatment for congenital toxoplasmosis.
by: Marta Gutiérrez-Valencia, et al.
Published: (2025-07-01) -
Potential bias in the analysis of prenatal treatment for congenital toxoplasmosis
by: Marta Gutiérrez-Valencia, et al.
Published: (2025-07-01) -
Response to comment on: [Potential bias in the analysis of prenatal treatment for congenital toxoplasmosis].
by: Borja Guarch-Ibáñez, et al.
Published: (2025-07-01) -
Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study.
by: Mario Cortina-Borja, et al.
Published: (2010-10-01) -
Expansion of non-invasive prenatal screening to the screening of 10 types of chromosomal anomalies: a cost-effectiveness analysis
by: Julian Little, et al.
Published: (2023-08-01)